2001
DOI: 10.1073/pnas.071432398
|View full text |Cite
|
Sign up to set email alerts
|

Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection

Abstract: Retrovirus infection is initiated by receptor-dependent fusion of the envelope to the cell membrane. The modular organization of the envelope protein of C type retroviruses has been exploited to investigate how binding of the surface subunit (SU) to receptor triggers fusion mediated by the transmembrane (TM) subunit. We show that deletion of the receptor-binding domain (RBD) from SU of Friend murine leukemia virus (Fr-MLV) abolishes infection that is restored by supplying RBD as a soluble protein. Infection by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
97
1

Year Published

2003
2003
2013
2013

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 71 publications
(100 citation statements)
references
References 36 publications
1
97
1
Order By: Relevance
“…According to the prevailing model, the receptor triggers changes in the SU subunit, including isomerization of the intersubunit disulfide (14)(15)(16). As a result, the TM subunits can refold, probably first into the putative extended form that can reach the target cell membrane with its N-terminal fusion peptide, and then into the backfolded form, the formation of which is thought to drag the viral and cell membranes together for fusion.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to the prevailing model, the receptor triggers changes in the SU subunit, including isomerization of the intersubunit disulfide (14)(15)(16). As a result, the TM subunits can refold, probably first into the putative extended form that can reach the target cell membrane with its N-terminal fusion peptide, and then into the backfolded form, the formation of which is thought to drag the viral and cell membranes together for fusion.…”
Section: Discussionmentioning
confidence: 99%
“…Receptor binding has been suggested to trigger a cascade of conformational signals from RBD to TM via the C-terminal SU domain (14,15). The SU and TM are coupled by a disulfide bond, and activation requires its isomerization (16).…”
mentioning
confidence: 99%
“…The CETTG motif, which is involved in fusion activity (18), was disrupted by mutations in both KoRV-A and KoRV-J. KoRV-J had a replacement of Gln with Arg in the PHQ motif, which is important for the fusion activity (19)(20)(21)(22). Other important motifs that influence the functions of Env and/or the viral infectivity were highly conserved between the two subgroups.…”
mentioning
confidence: 99%
“…Examples of insertion sites in type C mammalian retrovirus glycoproteins -mainly the ecotropic and amphotropic MLV glycoproteins -that have been characterised and found to be functional, at least for retargeted binding, are shown in Figure 1. They include modifications of the glycoprotein such as (1) domain replacement [74][75][76], (2) peptide insertion in pre-folded domains [68,[77][78][79][80], and (3) display of polypeptides as additional folded domains [81][82][83][84][85][86][87][88][89][90][91][92]. Many of these chimeric glycoproteins fold correctly, are stably incorporated on virions and allow efficient retargeted virion binding to the expected cell-surface molecules.…”
Section: Ligand-fused Glycoproteins To Retarget Lentiviral Vectorsmentioning
confidence: 99%
“…Closer examination of the molecular mechanism that couples binding to the natural retroviral receptors to fusion activation has in fact revealed the very sophisticated solution adopted by retroviruses to coordinate these two functions. This coupling involves complex interrelations between the different subdomains of the glycoprotein complex [66,74,[101][102][103][104][105]. Attempts to reconstitute this coupling via the interaction of a non-viral target receptor to a non-viral ligand have so far been unsuccessful, even when inserted into a fusion-competent retroviral glycoprotein [106].…”
Section: Ligand-fused Glycoproteins To Retarget Lentiviral Vectorsmentioning
confidence: 99%